人のウォール街のアナリストによると、Cue Health Incの収益見積もりは$から$の範囲です。
Cue Health Incの収益品質スコアはどれくらいですか?
Cue Health Incの収益品質スコアはB+/48.90678です。このスコアは、収益性、成長、キャッシュ生成と資本配分、レバレッジの4つの次元に基づいています。
Cue Health Incはいつ収益を報告しますか?
Cue Health Incの次の収益報告は2025-02-04に予定されています
Cue Health Incの予想収益はいくらですか?
ウォール街のアナリストによると、Cue Health Incの予想収益は$13.81Mです。
Cue Health Incは収益予想を上回りましたか?
Cue Health Incの最近の収益は$で、予想を。
主要データ
前終値
$0
始値
$0
当日レンジ
$0 - $0
52週レンジ
$0 - $0.0001
取引高
12.8K
平均取引高
6.3K
配当利回り
--
1株当たり利益(TTM)
-2.44
時価総額
$159.09
HLTHQとは何ですか?
Cue Health, Inc. is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care. The company is headquartered in San Diego, California and currently employs 726 full-time employees. The company went IPO on 2021-09-24. The firm uses diagnostic-enabled care to enable people to live their healthiest lives. Its proprietary platform, the Cue Integrated Care Platform, which is comprised of its Cue Health Monitoring System, Cue Data and Innovation Layer, Cue Virtual Care Delivery Apps, Cue Ecosystem Integrations and Apps, and access to additional Cue-branded and third-party diagnostic products, enables lab-quality diagnostics-led care at home, at work or at the point of care. Its platform offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. The Cue Health Monitoring System is designed to deliver a menu of tests through one system, enabling two testing modalities, nucleic acid amplification and immunoassays, in one device.